These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group. Neurology; 1985 Aug; 35(8):1096-104. PubMed ID: 4022342 [TBL] [Abstract][Full Text] [Related]
24. Do corticosteroids influence the disease course or mortality of Guillain Barre syndrome? Mehndiratta MM J Assoc Physicians India; 1996 Jun; 44(6):431. PubMed ID: 9282570 [No Abstract] [Full Text] [Related]
25. Recurrence of childhood Guillain-Barré syndrome after a long asymptomatic interval: a case report. Martic V; Lepic T J Clin Neuromuscul Dis; 2007 Sep; 9(1):256-61. PubMed ID: 17989590 [TBL] [Abstract][Full Text] [Related]
26. [Bilateral peripheral facial paralysis and Guillain-Barré syndrome]. García Callejo FJ; Velert Vila MM; Pardo Mateu L; Mallea Cañizares I; Marco Algarra J Acta Otorrinolaringol Esp; 1998 Oct; 49(7):561-8. PubMed ID: 9866223 [TBL] [Abstract][Full Text] [Related]
27. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338 [TBL] [Abstract][Full Text] [Related]
28. [Clinical study of seven patients with facial diplegia. Its differentiation between Bell's palsy and variant form of Guillain-Barré syndrome]. Saito T; Kowa H; Shimizu Y; Torii J; Tazaki Y Rinsho Shinkeigaku; 1984 Jul; 24(7):670-8. PubMed ID: 6499335 [No Abstract] [Full Text] [Related]
30. Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barré syndrome. Sutter R; Mengiardi B; Lyrer P; Czaplinski A Neuromuscul Disord; 2009 Oct; 19(10):709-10. PubMed ID: 19616949 [TBL] [Abstract][Full Text] [Related]
31. Guillain-Barré syndrome during treatment with ofloxacin. Schmidt S; Cordt-Schlegel A; Heitmann R J Neurol; 1993 Sep; 240(8):506-7. PubMed ID: 8263558 [No Abstract] [Full Text] [Related]
32. [History of Guillain-Barré syndrome]. Schott B Rev Neurol (Paris); 1982; 138(12):931-8. PubMed ID: 6763295 [TBL] [Abstract][Full Text] [Related]
33. [Retention of urine caused by fecaloma in the course of a Guillain-Barre syndrome (author's transl)]. Nicolle MH; Hugues FC; Leche J Sem Hop; 1980 Mar 18-25; 56(11-12):565. PubMed ID: 6245459 [TBL] [Abstract][Full Text] [Related]
35. The Guillain-Barre syndrome following gold therapy. Dick DJ; Raman D Scand J Rheumatol; 1982; 11(2):119-20. PubMed ID: 7089501 [No Abstract] [Full Text] [Related]
36. Guillain-Barré syndrome complicating treatment with streptokinase. Taylor BV; Mastaglia FL; Stell R Med J Aust; 1995 Feb; 162(4):214-5. PubMed ID: 7877546 [No Abstract] [Full Text] [Related]
37. [A case of Guillain-Barré syndrome associated with bilateral ballism: an overlap between Fisher's syndrome and Guillain-Barré syndrome]. Odaka M; Yuki N; Arai M; Hirata K Rinsho Shinkeigaku; 1998 Aug; 38(8):745-9. PubMed ID: 9916521 [TBL] [Abstract][Full Text] [Related]
38. Guillain-Barré syndrome after exogenous gangliosides in Italy. Landi G; D'Alessandro R; Dossi BC; Ricci S; Simone IL; Ciccone A BMJ; 1993 Dec; 307(6917):1463-4. PubMed ID: 8281088 [No Abstract] [Full Text] [Related]
39. Possible association of Guillain-Barré syndrome with thrombolytic therapy. Eden KV JAMA; 1983 Apr; 249(15):2020-1. PubMed ID: 6834592 [No Abstract] [Full Text] [Related]
40. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?]. Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]